We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KYMR icon
451
Kymera Therapeutics
KYMR
$9.1B
$23M 0.04%
+572,926
New +$20.5M
IBM icon
452
IBM
IBM
$202B
$23M 0.04%
120,582
-306,464
-72% -$55.9M
TFC icon
453
Truist Financial
TFC
$63.2B
$22.9M 0.03%
586,805
+152,588
+35% +$5.58M
KSPI icon
454
Kaspi.kz JSC
KSPI
$16.3B
$22.8M 0.03%
+177,487
New +$18.2M
EWT icon
455
iShares MSCI Taiwan ETF
EWT
$10B
$22.7M 0.03%
467,211
+324,417
+227% +$15M
TOST icon
456
Toast
TOST
$16.8B
$22.7M 0.03%
912,572
-382,387
-30% -$7.92M
LNW
457
DELISTED
Light & Wonder
LNW
$22.7M 0.03%
222,706
+194,109
+679% +$17.5M
TOL icon
458
Toll Brothers
TOL
$14B
$22.7M 0.03%
175,260
+156,628
+841% +$17M
CATX icon
459
Perspective Therapeutics
CATX
$332M
$22.6M 0.03%
+1,897,173
New +$16.2M
ETN icon
460
Eaton
ETN
$157B
$22.5M 0.03%
+72,113
New +$19.7M
EDR
461
DELISTED
Endeavor Group Holdings, Inc.
EDR
$22.5M 0.03%
875,682
-190,969
-18% -$4.67M
O icon
462
Realty Income
O
$61.2B
$22.5M 0.03%
416,100
+184,388
+80% +$9.98M
RVTY icon
463
Revvity
RVTY
$12.3B
$22.4M 0.03%
+213,707
New +$22.7M
MAS icon
464
Masco
MAS
$16B
$22.4M 0.03%
+284,205
New +$20.5M
HCP
465
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$22.3M 0.03%
829,185
+59,872
+8% +$1.45M
OPRA
466
Opera Ltd
OPRA
$1.65B
$22.3M 0.03%
1,408,272
+180,362
+15% +$2.28M
CZR icon
467
Caesars Entertainment
CZR
$6.1B
$22.2M 0.03%
507,913
+143,873
+40% +$6.22M
JHG
468
DELISTED
Janus Henderson
JHG
$22.1M 0.03%
673,004
+321,709
+92% +$9.84M
GNRC icon
469
Generac Holdings
GNRC
$11.9B
$22M 0.03%
174,740
+99,530
+132% +$11.7M
MPWR icon
470
Monolithic Power Systems
MPWR
$65.5B
$21.9M 0.03%
32,343
+17,952
+125% +$12M
BPMC
471
DELISTED
Blueprint Medicines
BPMC
$21.8M 0.03%
+230,292
New +$19.8M
HUN icon
472
Huntsman Corp
HUN
$2.24B
$21.8M 0.03%
+837,206
New +$20.8M
WM icon
473
Waste Management
WM
$95.9B
$21.8M 0.03%
102,099
-6,476
-6% -$1.27M
ARM icon
474
Arm
ARM
$278B
$21.7M 0.03%
+173,518
New +$18.4M
JWN
475
DELISTED
Nordstrom
JWN
$21.7M 0.03%
1,069,262
+1,046,862
+4,673% +$19.8M

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.